Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Disease | 162 | 2023 | 5917 | 8.970 |
Why?
|
Diet | 202 | 2024 | 8005 | 7.120 |
Why?
|
Alcohol Drinking | 121 | 2023 | 4018 | 6.540 |
Why?
|
Food Services | 20 | 2024 | 205 | 5.970 |
Why?
|
Food Preferences | 23 | 2023 | 399 | 5.440 |
Why?
|
Fruit | 55 | 2023 | 1160 | 5.380 |
Why?
|
Vegetables | 53 | 2023 | 1195 | 4.600 |
Why?
|
Cardiovascular Diseases | 167 | 2024 | 15399 | 4.580 |
Why?
|
Feeding Behavior | 78 | 2022 | 3184 | 3.950 |
Why?
|
Flavonoids | 23 | 2023 | 443 | 3.540 |
Why?
|
Food Supply | 20 | 2023 | 543 | 3.450 |
Why?
|
Life Style | 83 | 2024 | 3886 | 3.280 |
Why?
|
Schools | 17 | 2024 | 1482 | 3.020 |
Why?
|
Food Labeling | 10 | 2023 | 179 | 3.000 |
Why?
|
Haptoglobins | 12 | 2024 | 167 | 3.000 |
Why?
|
Beverages | 25 | 2023 | 819 | 2.880 |
Why?
|
Diabetes Mellitus, Type 2 | 109 | 2024 | 12075 | 2.820 |
Why?
|
Prospective Studies | 434 | 2024 | 54137 | 2.630 |
Why?
|
Myocardial Infarction | 75 | 2024 | 11424 | 2.520 |
Why?
|
Risk Factors | 432 | 2024 | 73809 | 2.400 |
Why?
|
Food | 21 | 2024 | 771 | 2.380 |
Why?
|
Nutrition Policy | 21 | 2021 | 470 | 2.330 |
Why?
|
Nutritive Value | 14 | 2024 | 349 | 2.280 |
Why?
|
Exercise | 66 | 2023 | 5788 | 2.110 |
Why?
|
Middle Aged | 633 | 2024 | 219568 | 2.090 |
Why?
|
Homocysteine | 18 | 2015 | 638 | 2.050 |
Why?
|
Dietary Fats | 50 | 2019 | 1991 | 2.050 |
Why?
|
Body Mass Index | 127 | 2023 | 12876 | 2.020 |
Why?
|
Diet Surveys | 45 | 2024 | 1161 | 1.980 |
Why?
|
Follow-Up Studies | 247 | 2023 | 39059 | 1.950 |
Why?
|
Adult | 569 | 2024 | 219935 | 1.950 |
Why?
|
Dietary Fiber | 34 | 2021 | 759 | 1.890 |
Why?
|
Cholesterol, HDL | 34 | 2023 | 1808 | 1.830 |
Why?
|
Humans | 933 | 2024 | 758406 | 1.820 |
Why?
|
Lignans | 8 | 2022 | 82 | 1.800 |
Why?
|
Energy Intake | 42 | 2023 | 2127 | 1.780 |
Why?
|
Nurses | 44 | 2023 | 2467 | 1.770 |
Why?
|
Erectile Dysfunction | 11 | 2022 | 451 | 1.760 |
Why?
|
Adiponectin | 24 | 2023 | 1114 | 1.670 |
Why?
|
Anthocyanins | 11 | 2024 | 79 | 1.670 |
Why?
|
Male | 603 | 2024 | 358747 | 1.670 |
Why?
|
United States | 288 | 2024 | 72136 | 1.620 |
Why?
|
Aged | 466 | 2024 | 168218 | 1.620 |
Why?
|
Weight Gain | 27 | 2023 | 2346 | 1.600 |
Why?
|
Risk Reduction Behavior | 17 | 2024 | 1098 | 1.600 |
Why?
|
Seafood | 14 | 2021 | 390 | 1.590 |
Why?
|
Female | 555 | 2024 | 390323 | 1.580 |
Why?
|
Nutrition Surveys | 28 | 2022 | 1716 | 1.560 |
Why?
|
Cohort Studies | 218 | 2024 | 41256 | 1.510 |
Why?
|
Obesity | 73 | 2023 | 12870 | 1.500 |
Why?
|
Fatty Acids, Omega-3 | 22 | 2023 | 1373 | 1.480 |
Why?
|
Poverty | 18 | 2022 | 2692 | 1.480 |
Why?
|
Folic Acid | 27 | 2015 | 1309 | 1.480 |
Why?
|
Health Promotion | 15 | 2021 | 2204 | 1.460 |
Why?
|
Dietary Proteins | 16 | 2021 | 949 | 1.440 |
Why?
|
Dietary Carbohydrates | 21 | 2023 | 890 | 1.430 |
Why?
|
Proportional Hazards Models | 96 | 2024 | 12440 | 1.390 |
Why?
|
Fast Foods | 9 | 2023 | 210 | 1.370 |
Why?
|
Incidence | 159 | 2024 | 21272 | 1.340 |
Why?
|
Cause of Death | 29 | 2023 | 3675 | 1.330 |
Why?
|
Health Behavior | 21 | 2022 | 2617 | 1.330 |
Why?
|
Marketing | 8 | 2023 | 220 | 1.320 |
Why?
|
C-Reactive Protein | 31 | 2022 | 3812 | 1.290 |
Why?
|
Polymorphism, Genetic | 23 | 2014 | 4284 | 1.280 |
Why?
|
Nutritional Status | 17 | 2022 | 1607 | 1.200 |
Why?
|
Students | 11 | 2023 | 1734 | 1.200 |
Why?
|
Smoking | 82 | 2022 | 9051 | 1.170 |
Why?
|
Leisure Activities | 6 | 2022 | 306 | 1.170 |
Why?
|
Milk | 3 | 2019 | 443 | 1.160 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 5 | 2014 | 127 | 1.130 |
Why?
|
Hypertension | 46 | 2024 | 8499 | 1.120 |
Why?
|
Meat | 14 | 2021 | 584 | 1.110 |
Why?
|
Stroke | 37 | 2023 | 9694 | 1.100 |
Why?
|
Dietary Supplements | 25 | 2019 | 3387 | 1.090 |
Why?
|
Health Personnel | 63 | 2021 | 3312 | 1.090 |
Why?
|
Methylamines | 5 | 2021 | 137 | 1.090 |
Why?
|
Restaurants | 11 | 2023 | 230 | 1.080 |
Why?
|
Multivariate Analysis | 94 | 2020 | 12096 | 1.080 |
Why?
|
Family Characteristics | 10 | 2023 | 1000 | 1.060 |
Why?
|
Fishes | 18 | 2021 | 601 | 1.050 |
Why?
|
Case-Control Studies | 82 | 2021 | 22029 | 1.050 |
Why?
|
Coronary Artery Disease | 15 | 2024 | 6362 | 1.040 |
Why?
|
Health Surveys | 23 | 2020 | 4064 | 1.020 |
Why?
|
Wine | 13 | 2023 | 166 | 1.010 |
Why?
|
United States Department of Agriculture | 6 | 2019 | 47 | 1.010 |
Why?
|
Risk | 84 | 2020 | 9599 | 1.000 |
Why?
|
Cooking | 6 | 2019 | 311 | 1.000 |
Why?
|
Commerce | 8 | 2023 | 604 | 1.000 |
Why?
|
Genetic Loci | 13 | 2017 | 2612 | 0.980 |
Why?
|
Diet Records | 21 | 2024 | 427 | 0.980 |
Why?
|
Mortality | 17 | 2022 | 2886 | 0.960 |
Why?
|
Stress Disorders, Post-Traumatic | 20 | 2024 | 4560 | 0.940 |
Why?
|
Vitamin E | 20 | 2016 | 870 | 0.930 |
Why?
|
Hypercholesterolemia | 19 | 2022 | 1138 | 0.920 |
Why?
|
Flavanones | 7 | 2016 | 73 | 0.910 |
Why?
|
Mendelian Randomization Analysis | 9 | 2020 | 993 | 0.910 |
Why?
|
Sodium, Dietary | 6 | 2024 | 425 | 0.910 |
Why?
|
School Health Services | 5 | 2023 | 380 | 0.900 |
Why?
|
Motor Activity | 15 | 2018 | 2685 | 0.890 |
Why?
|
Genome-Wide Association Study | 33 | 2023 | 12604 | 0.870 |
Why?
|
Ascorbic Acid | 15 | 2022 | 655 | 0.860 |
Why?
|
Nails | 10 | 2014 | 295 | 0.860 |
Why?
|
Trans Fatty Acids | 8 | 2016 | 155 | 0.850 |
Why?
|
Polymorphism, Single Nucleotide | 53 | 2019 | 15773 | 0.850 |
Why?
|
Receptors, Tumor Necrosis Factor | 11 | 2014 | 584 | 0.850 |
Why?
|
Leptin | 10 | 2023 | 1591 | 0.850 |
Why?
|
Diet, Mediterranean | 12 | 2023 | 736 | 0.830 |
Why?
|
Alcoholic Beverages | 11 | 2023 | 264 | 0.830 |
Why?
|
Antioxidants | 20 | 2016 | 1662 | 0.820 |
Why?
|
Genotype | 41 | 2018 | 12945 | 0.820 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 12 | 2022 | 346 | 0.820 |
Why?
|
Ethanol | 12 | 2021 | 1323 | 0.810 |
Why?
|
Body Weight | 24 | 2023 | 4603 | 0.800 |
Why?
|
Choice Behavior | 9 | 2023 | 821 | 0.790 |
Why?
|
Carotenoids | 16 | 2016 | 620 | 0.780 |
Why?
|
Carbohydrates | 3 | 2023 | 388 | 0.770 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 7 | 2011 | 275 | 0.760 |
Why?
|
Risk Assessment | 67 | 2024 | 23884 | 0.760 |
Why?
|
Selenium | 7 | 2014 | 416 | 0.760 |
Why?
|
Diet, Vegetarian | 8 | 2022 | 180 | 0.750 |
Why?
|
Solanum tuberosum | 5 | 2021 | 40 | 0.750 |
Why?
|
Genetic Predisposition to Disease | 43 | 2019 | 17768 | 0.740 |
Why?
|
Triglycerides | 15 | 2021 | 2451 | 0.740 |
Why?
|
alpha-Linolenic Acid | 11 | 2016 | 144 | 0.730 |
Why?
|
Fatty Acids, Omega-6 | 8 | 2023 | 226 | 0.720 |
Why?
|
American Heart Association | 5 | 2021 | 1039 | 0.720 |
Why?
|
Food Analysis | 5 | 2021 | 103 | 0.710 |
Why?
|
Waist Circumference | 8 | 2021 | 921 | 0.710 |
Why?
|
Lipids | 23 | 2023 | 3326 | 0.710 |
Why?
|
Nutrition Assessment | 22 | 2022 | 726 | 0.710 |
Why?
|
C-Peptide | 9 | 2023 | 433 | 0.700 |
Why?
|
Diet Therapy | 2 | 2021 | 150 | 0.700 |
Why?
|
Insulin | 16 | 2022 | 6578 | 0.690 |
Why?
|
Primary Prevention | 6 | 2020 | 1185 | 0.680 |
Why?
|
Fatty Acids, Unsaturated | 10 | 2023 | 540 | 0.680 |
Why?
|
Survivors | 4 | 2014 | 2370 | 0.680 |
Why?
|
Soy Milk | 1 | 2019 | 4 | 0.670 |
Why?
|
Longitudinal Studies | 53 | 2023 | 14490 | 0.670 |
Why?
|
Public Assistance | 1 | 2019 | 47 | 0.660 |
Why?
|
Inflammation | 25 | 2023 | 10718 | 0.660 |
Why?
|
Cross-Sectional Studies | 61 | 2024 | 25956 | 0.650 |
Why?
|
Food Contamination | 5 | 2019 | 192 | 0.650 |
Why?
|
Genetic Variation | 17 | 2019 | 6548 | 0.650 |
Why?
|
Overweight | 14 | 2023 | 2411 | 0.640 |
Why?
|
Flavoring Agents | 1 | 2019 | 53 | 0.640 |
Why?
|
Coffee | 12 | 2023 | 582 | 0.640 |
Why?
|
Genetic Pleiotropy | 1 | 2019 | 181 | 0.620 |
Why?
|
Daucus carota | 1 | 2017 | 10 | 0.610 |
Why?
|
Isoflavones | 4 | 2022 | 136 | 0.610 |
Why?
|
Food-Processing Industry | 1 | 2017 | 14 | 0.610 |
Why?
|
Cholesterol | 19 | 2023 | 2902 | 0.610 |
Why?
|
Cardiovascular System | 4 | 2023 | 835 | 0.600 |
Why?
|
Cholesterol, LDL | 13 | 2021 | 2374 | 0.590 |
Why?
|
Methylmercury Compounds | 3 | 2012 | 102 | 0.590 |
Why?
|
Eating | 14 | 2023 | 1536 | 0.590 |
Why?
|
Personnel, Hospital | 4 | 2021 | 285 | 0.590 |
Why?
|
Diet, Carbohydrate-Restricted | 4 | 2023 | 261 | 0.570 |
Why?
|
Dairy Products | 11 | 2020 | 491 | 0.570 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 6 | 2017 | 691 | 0.570 |
Why?
|
Intercellular Signaling Peptides and Proteins | 7 | 2005 | 1651 | 0.560 |
Why?
|
Dietary Fats, Unsaturated | 8 | 2017 | 224 | 0.550 |
Why?
|
Apolipoproteins B | 9 | 2013 | 385 | 0.550 |
Why?
|
Beer | 9 | 2023 | 134 | 0.550 |
Why?
|
Phospholipids | 7 | 2015 | 784 | 0.540 |
Why?
|
Child | 46 | 2024 | 79818 | 0.530 |
Why?
|
Nuts | 4 | 2019 | 263 | 0.530 |
Why?
|
Heart Diseases | 8 | 2022 | 2782 | 0.530 |
Why?
|
Neoplasms | 36 | 2023 | 22032 | 0.530 |
Why?
|
Poultry | 2 | 2016 | 81 | 0.520 |
Why?
|
Alcohol Dehydrogenase | 5 | 2014 | 111 | 0.520 |
Why?
|
Women's Health | 9 | 2018 | 2057 | 0.520 |
Why?
|
Plant Oils | 6 | 2014 | 197 | 0.520 |
Why?
|
Body Composition | 9 | 2018 | 2416 | 0.510 |
Why?
|
Food, Organic | 1 | 2015 | 34 | 0.510 |
Why?
|
Time Factors | 56 | 2024 | 39872 | 0.510 |
Why?
|
Television | 6 | 2019 | 409 | 0.510 |
Why?
|
Aged, 80 and over | 70 | 2024 | 58683 | 0.500 |
Why?
|
4-Butyrolactone | 3 | 2022 | 61 | 0.500 |
Why?
|
Preventive Health Services | 3 | 2016 | 570 | 0.490 |
Why?
|
Interleukin-6 | 11 | 2022 | 3208 | 0.490 |
Why?
|
Logistic Models | 46 | 2019 | 13276 | 0.490 |
Why?
|
Spectrometry, Fluorescence | 2 | 2007 | 681 | 0.490 |
Why?
|
Self Report | 18 | 2024 | 3714 | 0.490 |
Why?
|
Age Distribution | 20 | 2015 | 2882 | 0.490 |
Why?
|
Mercury | 4 | 2012 | 288 | 0.480 |
Why?
|
Flavonols | 9 | 2020 | 83 | 0.480 |
Why?
|
Health Status | 12 | 2022 | 4071 | 0.470 |
Why?
|
Waste Products | 1 | 2014 | 12 | 0.470 |
Why?
|
Video Games | 1 | 2016 | 191 | 0.470 |
Why?
|
Betaine | 3 | 2024 | 89 | 0.460 |
Why?
|
Flavones | 7 | 2020 | 67 | 0.460 |
Why?
|
Blood Glucose | 16 | 2024 | 6346 | 0.450 |
Why?
|
Phytosterols | 2 | 2023 | 55 | 0.450 |
Why?
|
Adolescent | 52 | 2023 | 87892 | 0.440 |
Why?
|
Suicide | 7 | 2011 | 1599 | 0.440 |
Why?
|
Colorectal Neoplasms | 16 | 2023 | 6852 | 0.440 |
Why?
|
Chronic Disease | 19 | 2022 | 9267 | 0.440 |
Why?
|
Confidence Intervals | 19 | 2018 | 2925 | 0.440 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2022 | 517 | 0.430 |
Why?
|
Vitamin B Complex | 6 | 2015 | 297 | 0.430 |
Why?
|
Massachusetts | 16 | 2022 | 8823 | 0.430 |
Why?
|
Sex Factors | 29 | 2021 | 10504 | 0.420 |
Why?
|
Odds Ratio | 37 | 2019 | 9650 | 0.420 |
Why?
|
Epidemiologic Studies | 7 | 2022 | 670 | 0.420 |
Why?
|
Weight Loss | 9 | 2024 | 2671 | 0.420 |
Why?
|
Phenotype | 21 | 2024 | 16534 | 0.420 |
Why?
|
Fatty Acids | 9 | 2018 | 1803 | 0.420 |
Why?
|
Docosahexaenoic Acids | 7 | 2023 | 905 | 0.410 |
Why?
|
Micronutrients | 4 | 2022 | 381 | 0.410 |
Why?
|
Aging | 14 | 2017 | 8650 | 0.400 |
Why?
|
Age Factors | 45 | 2021 | 18358 | 0.400 |
Why?
|
Lipoproteins, LDL | 4 | 2013 | 640 | 0.400 |
Why?
|
Walking | 5 | 2020 | 1188 | 0.400 |
Why?
|
Choline | 3 | 2021 | 513 | 0.400 |
Why?
|
Behavior, Addictive | 2 | 2016 | 462 | 0.400 |
Why?
|
Lipoproteins, HDL | 5 | 2020 | 664 | 0.390 |
Why?
|
Diabetes Mellitus | 17 | 2023 | 5816 | 0.390 |
Why?
|
Pyridoxine | 6 | 2001 | 108 | 0.390 |
Why?
|
Inflammation Mediators | 6 | 2021 | 1878 | 0.380 |
Why?
|
Plant Extracts | 2 | 2015 | 489 | 0.380 |
Why?
|
Tea | 9 | 2023 | 284 | 0.380 |
Why?
|
Epidemiologic Methods | 9 | 2019 | 1338 | 0.380 |
Why?
|
Reproducibility of Results | 28 | 2024 | 20055 | 0.380 |
Why?
|
Brain Ischemia | 9 | 2020 | 3047 | 0.380 |
Why?
|
Maine | 3 | 2021 | 145 | 0.380 |
Why?
|
Young Adult | 36 | 2023 | 58808 | 0.380 |
Why?
|
Procollagen | 4 | 2015 | 187 | 0.370 |
Why?
|
Refuse Disposal | 2 | 2022 | 31 | 0.370 |
Why?
|
Vitamin D | 12 | 2017 | 3283 | 0.370 |
Why?
|
Environmental Exposure | 6 | 2024 | 4412 | 0.370 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 4 | 2004 | 256 | 0.370 |
Why?
|
Linear Models | 21 | 2018 | 5862 | 0.370 |
Why?
|
Cholesterol Ester Transfer Proteins | 3 | 2007 | 113 | 0.360 |
Why?
|
Regression Analysis | 30 | 2016 | 6354 | 0.360 |
Why?
|
Prevalence | 33 | 2024 | 15651 | 0.360 |
Why?
|
Feces | 5 | 2021 | 1456 | 0.360 |
Why?
|
Health Education | 2 | 2017 | 1049 | 0.350 |
Why?
|
Plant Proteins | 2 | 2023 | 369 | 0.350 |
Why?
|
Systems Biology | 1 | 2013 | 482 | 0.350 |
Why?
|
Health Occupations | 8 | 2019 | 222 | 0.340 |
Why?
|
Anthropometry | 14 | 2018 | 1347 | 0.340 |
Why?
|
Patient Compliance | 3 | 2016 | 2685 | 0.340 |
Why?
|
Lipase | 6 | 2012 | 324 | 0.340 |
Why?
|
Pre-Eclampsia | 4 | 2022 | 1227 | 0.340 |
Why?
|
Myocardial Ischemia | 4 | 2010 | 2108 | 0.330 |
Why?
|
Pyridoxal Phosphate | 1 | 2009 | 124 | 0.330 |
Why?
|
Metagenome | 3 | 2024 | 450 | 0.330 |
Why?
|
Lipoproteins | 5 | 2021 | 881 | 0.330 |
Why?
|
Adipose Tissue | 11 | 2017 | 3299 | 0.330 |
Why?
|
Prostatic Neoplasms | 28 | 2021 | 11336 | 0.330 |
Why?
|
Death, Sudden, Cardiac | 9 | 2012 | 1554 | 0.330 |
Why?
|
Aryldialkylphosphatase | 1 | 2009 | 62 | 0.330 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.330 |
Why?
|
Heterozygote | 3 | 2015 | 2797 | 0.330 |
Why?
|
Sleep | 6 | 2023 | 4744 | 0.330 |
Why?
|
Endothelium, Vascular | 8 | 2021 | 4429 | 0.320 |
Why?
|
Lipid Metabolism | 5 | 2020 | 1895 | 0.320 |
Why?
|
Workplace | 5 | 2023 | 857 | 0.320 |
Why?
|
Apolipoprotein C-III | 3 | 2017 | 208 | 0.320 |
Why?
|
Body Constitution | 7 | 2000 | 273 | 0.320 |
Why?
|
Diabetic Angiopathies | 7 | 2012 | 802 | 0.310 |
Why?
|
Sex Distribution | 11 | 2014 | 2284 | 0.310 |
Why?
|
Phytotherapy | 1 | 2010 | 295 | 0.310 |
Why?
|
New England | 4 | 2021 | 1053 | 0.310 |
Why?
|
Premature Birth | 5 | 2021 | 1771 | 0.310 |
Why?
|
Peripheral Arterial Disease | 6 | 2015 | 1246 | 0.300 |
Why?
|
Cell Adhesion Molecules | 3 | 2015 | 1600 | 0.300 |
Why?
|
Secondary Prevention | 1 | 2014 | 1474 | 0.300 |
Why?
|
Lipotropic Agents | 1 | 2007 | 13 | 0.300 |
Why?
|
Food Handling | 4 | 2020 | 155 | 0.300 |
Why?
|
Citrus | 4 | 2024 | 44 | 0.300 |
Why?
|
Menu Planning | 2 | 2021 | 28 | 0.300 |
Why?
|
Complement Factor H | 2 | 2007 | 109 | 0.300 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 616 | 0.290 |
Why?
|
Executive Function | 1 | 2016 | 1374 | 0.290 |
Why?
|
Pregnancy Proteins | 1 | 2008 | 222 | 0.290 |
Why?
|
Marital Status | 4 | 2014 | 432 | 0.290 |
Why?
|
Caffeine | 9 | 2012 | 701 | 0.290 |
Why?
|
Galectin 2 | 1 | 2007 | 13 | 0.290 |
Why?
|
Intercellular Adhesion Molecule-1 | 5 | 2018 | 1125 | 0.290 |
Why?
|
Fructose | 3 | 2023 | 287 | 0.290 |
Why?
|
Fibrinogen | 7 | 2015 | 883 | 0.280 |
Why?
|
Parents | 5 | 2022 | 3548 | 0.280 |
Why?
|
Specimen Handling | 3 | 2021 | 707 | 0.280 |
Why?
|
Lymphotoxin-alpha | 1 | 2007 | 94 | 0.280 |
Why?
|
Pulmonary Embolism | 6 | 2019 | 2540 | 0.280 |
Why?
|
Creatinine | 7 | 2015 | 1892 | 0.280 |
Why?
|
beta Carotene | 11 | 2018 | 523 | 0.280 |
Why?
|
Community-Acquired Infections | 3 | 2009 | 460 | 0.280 |
Why?
|
Air Pollution | 4 | 2024 | 2314 | 0.280 |
Why?
|
Animals | 39 | 2023 | 167768 | 0.280 |
Why?
|
Guideline Adherence | 2 | 2016 | 2215 | 0.270 |
Why?
|
Vasodilator Agents | 1 | 2010 | 973 | 0.270 |
Why?
|
Statistics, Nonparametric | 7 | 2021 | 2850 | 0.260 |
Why?
|
Public Health | 8 | 2021 | 2658 | 0.260 |
Why?
|
Mental Recall | 7 | 2022 | 1208 | 0.260 |
Why?
|
PPAR gamma | 2 | 2007 | 482 | 0.260 |
Why?
|
Predictive Value of Tests | 16 | 2024 | 15225 | 0.260 |
Why?
|
Glycemic Index | 7 | 2015 | 393 | 0.260 |
Why?
|
Hospitals | 1 | 2019 | 3887 | 0.260 |
Why?
|
Boston | 13 | 2021 | 9304 | 0.250 |
Why?
|
Kidney Calculi | 8 | 2013 | 468 | 0.250 |
Why?
|
Caregivers | 4 | 2022 | 2225 | 0.250 |
Why?
|
Macular Degeneration | 5 | 2023 | 1001 | 0.250 |
Why?
|
Thrombospondins | 1 | 2006 | 193 | 0.250 |
Why?
|
Temperance | 4 | 2010 | 87 | 0.250 |
Why?
|
Cysteine | 1 | 2010 | 893 | 0.250 |
Why?
|
Diabetes Complications | 6 | 2019 | 1317 | 0.250 |
Why?
|
Gene Frequency | 11 | 2014 | 3612 | 0.240 |
Why?
|
Metabolomics | 3 | 2024 | 1629 | 0.240 |
Why?
|
F2-Isoprostanes | 1 | 2004 | 35 | 0.240 |
Why?
|
Blood Specimen Collection | 2 | 2003 | 238 | 0.240 |
Why?
|
Socioeconomic Factors | 10 | 2019 | 7818 | 0.240 |
Why?
|
Sweetening Agents | 4 | 2023 | 290 | 0.240 |
Why?
|
Malondialdehyde | 1 | 2004 | 111 | 0.240 |
Why?
|
Endometriosis | 3 | 2018 | 874 | 0.240 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 2 | 2016 | 62 | 0.240 |
Why?
|
Cholelithiasis | 5 | 2001 | 407 | 0.240 |
Why?
|
ABO Blood-Group System | 3 | 2012 | 367 | 0.240 |
Why?
|
Proteins | 5 | 2015 | 6026 | 0.230 |
Why?
|
Periodontal Diseases | 4 | 2004 | 451 | 0.230 |
Why?
|
Acute-Phase Proteins | 1 | 2005 | 250 | 0.230 |
Why?
|
Models, Genetic | 4 | 2020 | 3441 | 0.230 |
Why?
|
Linoleic Acid | 4 | 2023 | 158 | 0.230 |
Why?
|
Hypolipidemic Agents | 2 | 2022 | 609 | 0.230 |
Why?
|
Vitamin B 6 | 5 | 2015 | 233 | 0.230 |
Why?
|
Heme | 2 | 2024 | 313 | 0.230 |
Why?
|
Income | 4 | 2021 | 1872 | 0.230 |
Why?
|
Carbon Footprint | 1 | 2023 | 19 | 0.230 |
Why?
|
Sulfur | 2 | 2021 | 163 | 0.230 |
Why?
|
Food, Fortified | 3 | 2013 | 189 | 0.230 |
Why?
|
Motivation | 5 | 2022 | 1996 | 0.220 |
Why?
|
Smoking Cessation | 3 | 2020 | 2055 | 0.220 |
Why?
|
Internet | 3 | 2022 | 3082 | 0.220 |
Why?
|
Telomere | 1 | 2010 | 931 | 0.220 |
Why?
|
Arachidonic Acid | 3 | 2023 | 427 | 0.220 |
Why?
|
Transforming Growth Factor beta | 4 | 2015 | 1958 | 0.220 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2007 | 563 | 0.220 |
Why?
|
Gallstones | 2 | 2016 | 283 | 0.220 |
Why?
|
Alcoholism | 2 | 2013 | 1962 | 0.220 |
Why?
|
Central Nervous System Depressants | 2 | 2021 | 164 | 0.220 |
Why?
|
Blood Pressure | 13 | 2021 | 8451 | 0.220 |
Why?
|
Insulin Resistance | 9 | 2020 | 3941 | 0.220 |
Why?
|
Child Nutritional Physiological Phenomena | 3 | 2016 | 295 | 0.220 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 487 | 0.220 |
Why?
|
Reference Values | 8 | 2010 | 4919 | 0.210 |
Why?
|
Phobic Disorders | 3 | 2014 | 437 | 0.210 |
Why?
|
Diet, Fat-Restricted | 3 | 2017 | 329 | 0.210 |
Why?
|
Calcium, Dietary | 8 | 2006 | 529 | 0.210 |
Why?
|
Animal Welfare | 1 | 2022 | 19 | 0.210 |
Why?
|
Sterilization, Tubal | 1 | 2023 | 80 | 0.210 |
Why?
|
Occupational Health Services | 2 | 2021 | 150 | 0.210 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 5103 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 16 | 2024 | 10146 | 0.210 |
Why?
|
Body Height | 8 | 2017 | 1567 | 0.210 |
Why?
|
Adenomatous Polyps | 2 | 2021 | 108 | 0.210 |
Why?
|
Malus | 4 | 2016 | 50 | 0.210 |
Why?
|
Physical Fitness | 5 | 2014 | 732 | 0.200 |
Why?
|
Quality Improvement | 1 | 2017 | 3806 | 0.200 |
Why?
|
Waste Management | 1 | 2022 | 19 | 0.200 |
Why?
|
Particulate Matter | 3 | 2024 | 2556 | 0.200 |
Why?
|
Infant | 9 | 2022 | 36055 | 0.200 |
Why?
|
Vitamins | 5 | 2007 | 1632 | 0.200 |
Why?
|
Colonic Polyps | 5 | 2021 | 551 | 0.200 |
Why?
|
Uncertainty | 1 | 2007 | 751 | 0.200 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 655 | 0.200 |
Why?
|
Persea | 1 | 2022 | 18 | 0.200 |
Why?
|
Dietary Sucrose | 3 | 2017 | 244 | 0.200 |
Why?
|
Atherosclerosis | 6 | 2014 | 3401 | 0.200 |
Why?
|
Depression | 7 | 2020 | 8057 | 0.200 |
Why?
|
Home Nursing | 1 | 2002 | 92 | 0.200 |
Why?
|
Fragaria | 2 | 2013 | 21 | 0.200 |
Why?
|
Family Health | 3 | 2003 | 1257 | 0.200 |
Why?
|
Fasting | 6 | 2014 | 1599 | 0.200 |
Why?
|
Pneumonia | 3 | 2009 | 2129 | 0.200 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 4 | 2017 | 415 | 0.200 |
Why?
|
Meta-Analysis as Topic | 4 | 2013 | 1373 | 0.200 |
Why?
|
Biological Specimen Banks | 2 | 2018 | 782 | 0.200 |
Why?
|
Health | 4 | 2021 | 398 | 0.200 |
Why?
|
Seasons | 2 | 2018 | 1519 | 0.200 |
Why?
|
Sulfur-Reducing Bacteria | 1 | 2021 | 15 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Social Support | 5 | 2017 | 2155 | 0.190 |
Why?
|
Vitamin B 12 | 8 | 2015 | 522 | 0.190 |
Why?
|
Fenofibrate | 1 | 2022 | 87 | 0.190 |
Why?
|
Sulfur Compounds | 1 | 2021 | 32 | 0.190 |
Why?
|
Nitrogen Dioxide | 1 | 2024 | 512 | 0.190 |
Why?
|
Mental Health | 3 | 2017 | 3234 | 0.190 |
Why?
|
Nitrates | 2 | 2022 | 263 | 0.190 |
Why?
|
Random Allocation | 5 | 2022 | 2385 | 0.190 |
Why?
|
Program Evaluation | 5 | 2022 | 2492 | 0.190 |
Why?
|
Acute Coronary Syndrome | 3 | 2013 | 2180 | 0.190 |
Why?
|
Peptide Fragments | 5 | 2015 | 5098 | 0.190 |
Why?
|
Diverticulitis | 2 | 2021 | 182 | 0.190 |
Why?
|
Lipid Peroxidation | 4 | 2007 | 271 | 0.190 |
Why?
|
Shellfish | 1 | 2020 | 37 | 0.190 |
Why?
|
Energy Metabolism | 5 | 2018 | 2868 | 0.190 |
Why?
|
Bacteria | 3 | 2021 | 2197 | 0.190 |
Why?
|
Myocardial Revascularization | 2 | 2016 | 792 | 0.180 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2023 | 1079 | 0.180 |
Why?
|
Arteriosclerosis | 2 | 2003 | 1055 | 0.180 |
Why?
|
Oxidative Stress | 6 | 2013 | 3099 | 0.180 |
Why?
|
California | 2 | 2022 | 1419 | 0.180 |
Why?
|
Life Expectancy | 3 | 2020 | 1244 | 0.180 |
Why?
|
Electronic Mail | 2 | 2019 | 213 | 0.180 |
Why?
|
Child, Preschool | 12 | 2022 | 42062 | 0.180 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2016 | 296 | 0.180 |
Why?
|
Prostatic Hyperplasia | 7 | 2000 | 530 | 0.180 |
Why?
|
Colonic Neoplasms | 9 | 2012 | 2523 | 0.180 |
Why?
|
Herpes Zoster | 1 | 2022 | 251 | 0.170 |
Why?
|
Environmental Health | 1 | 2022 | 284 | 0.170 |
Why?
|
Venous Thromboembolism | 4 | 2019 | 1855 | 0.170 |
Why?
|
Forecasting | 5 | 2017 | 2923 | 0.170 |
Why?
|
Cacao | 3 | 2012 | 98 | 0.170 |
Why?
|
Temperature | 2 | 2024 | 2219 | 0.170 |
Why?
|
Resistin | 2 | 2012 | 172 | 0.170 |
Why?
|
Restless Legs Syndrome | 2 | 2013 | 233 | 0.170 |
Why?
|
Sports | 4 | 2016 | 699 | 0.170 |
Why?
|
Prognosis | 19 | 2020 | 29557 | 0.170 |
Why?
|
Linkage Disequilibrium | 4 | 2010 | 1996 | 0.170 |
Why?
|
Diabetic Nephropathies | 2 | 2023 | 973 | 0.170 |
Why?
|
Weights and Measures | 1 | 2019 | 41 | 0.170 |
Why?
|
Melatonin | 2 | 2016 | 668 | 0.170 |
Why?
|
Corneal Diseases | 1 | 2005 | 536 | 0.170 |
Why?
|
Glutathione Peroxidase | 2 | 2014 | 255 | 0.170 |
Why?
|
Comorbidity | 10 | 2018 | 10495 | 0.170 |
Why?
|
Analysis of Variance | 7 | 2014 | 6234 | 0.160 |
Why?
|
Periodontitis | 3 | 2015 | 558 | 0.160 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2017 | 1927 | 0.160 |
Why?
|
Air Pollutants | 2 | 2024 | 2842 | 0.160 |
Why?
|
Diabetic Neuropathies | 1 | 2023 | 405 | 0.160 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2001 | 590 | 0.160 |
Why?
|
Phylogeny | 2 | 2024 | 2774 | 0.160 |
Why?
|
Pancreatic Diseases | 1 | 2001 | 343 | 0.160 |
Why?
|
Pilot Projects | 5 | 2019 | 8553 | 0.160 |
Why?
|
Pesticide Residues | 1 | 2019 | 95 | 0.160 |
Why?
|
Sphingosine N-Acyltransferase | 1 | 2018 | 6 | 0.160 |
Why?
|
Diabetic Foot | 1 | 2023 | 380 | 0.160 |
Why?
|
Peripheral Vascular Diseases | 3 | 2008 | 488 | 0.160 |
Why?
|
Adenoma | 10 | 2004 | 2148 | 0.150 |
Why?
|
Abdomen | 2 | 2005 | 1129 | 0.150 |
Why?
|
Beta vulgaris | 1 | 2017 | 7 | 0.150 |
Why?
|
Quantitative Trait, Heritable | 2 | 2016 | 540 | 0.150 |
Why?
|
Pregnancy | 17 | 2022 | 29742 | 0.150 |
Why?
|
Fibroblast Growth Factors | 3 | 2014 | 867 | 0.150 |
Why?
|
Tooth Loss | 4 | 2004 | 198 | 0.150 |
Why?
|
Sodium | 4 | 2024 | 1588 | 0.150 |
Why?
|
Hormone Replacement Therapy | 3 | 2020 | 754 | 0.150 |
Why?
|
Radioimmunoassay | 3 | 2007 | 866 | 0.150 |
Why?
|
Parathyroid Hormone | 2 | 2017 | 1797 | 0.150 |
Why?
|
Bayes Theorem | 3 | 2023 | 2322 | 0.150 |
Why?
|
Body Fluid Compartments | 1 | 2017 | 50 | 0.150 |
Why?
|
Nutritional Requirements | 1 | 2019 | 275 | 0.150 |
Why?
|
Catechin | 3 | 2015 | 69 | 0.150 |
Why?
|
Adiposity | 3 | 2017 | 1858 | 0.150 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 469 | 0.150 |
Why?
|
Models, Biological | 4 | 2021 | 9460 | 0.140 |
Why?
|
Antihypertensive Agents | 2 | 2007 | 2016 | 0.140 |
Why?
|
Poisons | 1 | 1997 | 38 | 0.140 |
Why?
|
Hyperinsulinism | 1 | 2020 | 400 | 0.140 |
Why?
|
Asparagus Plant | 1 | 2016 | 4 | 0.140 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2007 | 1214 | 0.140 |
Why?
|
Alcoholic Intoxication | 1 | 2018 | 174 | 0.140 |
Why?
|
Urinary Retention | 5 | 1999 | 106 | 0.140 |
Why?
|
Nutritional Physiological Phenomena | 5 | 2012 | 362 | 0.140 |
Why?
|
Longevity | 1 | 2004 | 1050 | 0.140 |
Why?
|
Nutritional Sciences | 1 | 2018 | 143 | 0.140 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9404 | 0.140 |
Why?
|
Membrane Proteins | 3 | 2015 | 7843 | 0.140 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.140 |
Why?
|
Denmark | 5 | 2021 | 759 | 0.140 |
Why?
|
Nitroglycerin | 1 | 2017 | 328 | 0.140 |
Why?
|
Myosins | 1 | 2018 | 405 | 0.140 |
Why?
|
Vitamin D-Binding Protein | 1 | 2017 | 131 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3801 | 0.130 |
Why?
|
Plant Roots | 1 | 2016 | 114 | 0.130 |
Why?
|
DNA | 3 | 2014 | 7199 | 0.130 |
Why?
|
Water | 3 | 2023 | 1402 | 0.130 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
Drinking Behavior | 2 | 2011 | 103 | 0.130 |
Why?
|
Cystatin C | 2 | 2015 | 270 | 0.130 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2017 | 190 | 0.130 |
Why?
|
Heart Defects, Congenital | 3 | 2018 | 4673 | 0.130 |
Why?
|
Plants, Edible | 1 | 2015 | 29 | 0.130 |
Why?
|
Hip Fractures | 3 | 2019 | 987 | 0.130 |
Why?
|
Acetaminophen | 3 | 2007 | 552 | 0.130 |
Why?
|
Internationality | 1 | 2021 | 1000 | 0.130 |
Why?
|
Respiratory Tract Diseases | 1 | 2021 | 747 | 0.130 |
Why?
|
Postmenopause | 6 | 2014 | 2509 | 0.130 |
Why?
|
Menopause | 4 | 2016 | 1639 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2016 | 10748 | 0.130 |
Why?
|
Behavior Therapy | 1 | 2021 | 869 | 0.130 |
Why?
|
Rural Population | 2 | 2017 | 2254 | 0.130 |
Why?
|
Cytochrome P-450 CYP1A2 | 2 | 2014 | 69 | 0.120 |
Why?
|
Stillbirth | 1 | 2018 | 368 | 0.120 |
Why?
|
Fibrosis | 4 | 2015 | 2038 | 0.120 |
Why?
|
Lipoproteins, VLDL | 2 | 2013 | 201 | 0.120 |
Why?
|
Urine | 1 | 2016 | 363 | 0.120 |
Why?
|
Magnesium | 4 | 2004 | 809 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2018 | 3671 | 0.120 |
Why?
|
Tobacco Use Disorder | 2 | 2019 | 698 | 0.120 |
Why?
|
Puerperal Disorders | 1 | 2018 | 299 | 0.120 |
Why?
|
Waist-Hip Ratio | 2 | 2008 | 516 | 0.120 |
Why?
|
Endocrine System Diseases | 1 | 2017 | 249 | 0.120 |
Why?
|
Multifactorial Inheritance | 2 | 2014 | 1365 | 0.120 |
Why?
|
Factor VII | 2 | 2006 | 139 | 0.120 |
Why?
|
Dyssomnias | 1 | 2014 | 28 | 0.120 |
Why?
|
Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
Folic Acid Deficiency | 3 | 2012 | 117 | 0.120 |
Why?
|
Precancerous Conditions | 2 | 2021 | 977 | 0.120 |
Why?
|
Wounds and Injuries | 3 | 2019 | 2476 | 0.120 |
Why?
|
Parity | 4 | 2021 | 925 | 0.120 |
Why?
|
Biomedical Research | 3 | 2021 | 3418 | 0.120 |
Why?
|
Metagenomics | 4 | 2021 | 457 | 0.120 |
Why?
|
Body Size | 1 | 2017 | 462 | 0.120 |
Why?
|
NF-kappa B p50 Subunit | 2 | 2013 | 103 | 0.120 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3425 | 0.120 |
Why?
|
Phosphatidylcholines | 1 | 2016 | 405 | 0.120 |
Why?
|
Resistance Training | 1 | 2017 | 185 | 0.120 |
Why?
|
Vitamin A | 4 | 2001 | 613 | 0.120 |
Why?
|
Diet, Gluten-Free | 1 | 2017 | 280 | 0.120 |
Why?
|
Lipoprotein(a) | 4 | 2014 | 479 | 0.120 |
Why?
|
Metabolome | 4 | 2024 | 982 | 0.120 |
Why?
|
Seeds | 1 | 2014 | 119 | 0.120 |
Why?
|
Arsenic | 1 | 1997 | 358 | 0.120 |
Why?
|
Reimbursement, Incentive | 1 | 2019 | 540 | 0.120 |
Why?
|
Pancreas | 1 | 2001 | 1676 | 0.120 |
Why?
|
Parkinson Disease | 3 | 2016 | 2862 | 0.120 |
Why?
|
Olfaction Disorders | 1 | 2016 | 224 | 0.120 |
Why?
|
Catalase | 1 | 2014 | 216 | 0.110 |
Why?
|
Norway | 3 | 2020 | 496 | 0.110 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.110 |
Why?
|
Phytoestrogens | 2 | 2022 | 59 | 0.110 |
Why?
|
Residence Characteristics | 3 | 2020 | 2058 | 0.110 |
Why?
|
Models, Cardiovascular | 1 | 2019 | 972 | 0.110 |
Why?
|
Glutamic Acid | 2 | 2023 | 1167 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1081 | 0.110 |
Why?
|
Drug Utilization | 1 | 2019 | 1187 | 0.110 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2013 | 72 | 0.110 |
Why?
|
Actigraphy | 1 | 2017 | 518 | 0.110 |
Why?
|
Diabetic Retinopathy | 1 | 2023 | 1267 | 0.110 |
Why?
|
Abortion, Spontaneous | 1 | 2018 | 530 | 0.110 |
Why?
|
beta 2-Microglobulin | 1 | 2014 | 328 | 0.110 |
Why?
|
Molecular Weight | 2 | 2016 | 2185 | 0.110 |
Why?
|
Alleles | 6 | 2017 | 6895 | 0.110 |
Why?
|
Plants | 2 | 2019 | 317 | 0.110 |
Why?
|
Potassium, Dietary | 4 | 2024 | 103 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1020 | 0.110 |
Why?
|
Human Characteristics | 1 | 2012 | 7 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 906 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2014 | 2269 | 0.110 |
Why?
|
Urban Population | 3 | 2019 | 2025 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2017 | 1377 | 0.110 |
Why?
|
Apigenin | 2 | 2010 | 16 | 0.110 |
Why?
|
Focus Groups | 1 | 2018 | 1384 | 0.110 |
Why?
|
Geography | 2 | 2018 | 660 | 0.110 |
Why?
|
Prescription Drugs | 1 | 2020 | 626 | 0.110 |
Why?
|
zeta-Crystallins | 1 | 2012 | 4 | 0.110 |
Why?
|
Likelihood Functions | 3 | 2014 | 987 | 0.110 |
Why?
|
Genetic Markers | 3 | 2014 | 2608 | 0.110 |
Why?
|
Severity of Illness Index | 8 | 2017 | 15785 | 0.100 |
Why?
|
Cerebrovascular Disorders | 7 | 1999 | 1475 | 0.100 |
Why?
|
Sequence Deletion | 3 | 2013 | 1492 | 0.100 |
Why?
|
Cholecystectomy | 3 | 2003 | 406 | 0.100 |
Why?
|
Research Design | 5 | 2021 | 6157 | 0.100 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 529 | 0.100 |
Why?
|
Spinal Fractures | 1 | 2019 | 702 | 0.100 |
Why?
|
Educational Status | 2 | 2020 | 2513 | 0.100 |
Why?
|
Heart | 2 | 2023 | 4382 | 0.100 |
Why?
|
Apolipoproteins E | 2 | 2020 | 1436 | 0.100 |
Why?
|
Dyslipidemias | 2 | 2013 | 867 | 0.100 |
Why?
|
Adolescent Behavior | 2 | 2011 | 1184 | 0.100 |
Why?
|
Haplotypes | 2 | 2009 | 2764 | 0.100 |
Why?
|
Geographic Atrophy | 1 | 2013 | 82 | 0.100 |
Why?
|
Population Surveillance | 3 | 2016 | 2606 | 0.100 |
Why?
|
Intermittent Claudication | 1 | 2014 | 303 | 0.100 |
Why?
|
Social Change | 2 | 2010 | 152 | 0.100 |
Why?
|
Eicosapentaenoic Acid | 4 | 2023 | 560 | 0.100 |
Why?
|
Survival Rate | 10 | 2019 | 12721 | 0.100 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 593 | 0.100 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2012 | 240 | 0.100 |
Why?
|
Sulfotransferases | 1 | 2012 | 149 | 0.100 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2011 | 51 | 0.100 |
Why?
|
Constipation | 1 | 2016 | 561 | 0.100 |
Why?
|
Receptors, Oxytocin | 1 | 2012 | 68 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 2 | 2013 | 2248 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2017 | 2717 | 0.100 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 3069 | 0.100 |
Why?
|
Pregnancy Outcome | 2 | 2020 | 2907 | 0.090 |
Why?
|
Vaccinium | 1 | 2010 | 2 | 0.090 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4876 | 0.090 |
Why?
|
Birth Weight | 3 | 2011 | 2097 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2021 | 1196 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 635 | 0.090 |
Why?
|
Promoter Regions, Genetic | 3 | 2013 | 5779 | 0.090 |
Why?
|
Up-Regulation | 3 | 2018 | 4113 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7403 | 0.090 |
Why?
|
Analgesia, Patient-Controlled | 4 | 1995 | 116 | 0.090 |
Why?
|
Obesity, Abdominal | 1 | 2014 | 374 | 0.090 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2010 | 32 | 0.090 |
Why?
|
Carcinoma, Basal Cell | 3 | 2002 | 559 | 0.090 |
Why?
|
Postprandial Period | 2 | 2024 | 314 | 0.090 |
Why?
|
Taste | 1 | 2012 | 188 | 0.090 |
Why?
|
Sex Characteristics | 6 | 2012 | 2621 | 0.090 |
Why?
|
Wet Macular Degeneration | 1 | 2013 | 162 | 0.090 |
Why?
|
Acetyltransferases | 1 | 2012 | 231 | 0.090 |
Why?
|
Quality of Life | 2 | 2015 | 13285 | 0.090 |
Why?
|
Estradiol | 2 | 2012 | 1933 | 0.090 |
Why?
|
Receptors, Interleukin-6 | 1 | 2012 | 226 | 0.090 |
Why?
|
Potassium | 3 | 2024 | 1310 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11892 | 0.090 |
Why?
|
Widowhood | 2 | 2014 | 51 | 0.090 |
Why?
|
Venous Thrombosis | 2 | 2019 | 1292 | 0.090 |
Why?
|
Disease Progression | 6 | 2017 | 13468 | 0.090 |
Why?
|
Solubility | 2 | 2003 | 1088 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2011 | 303 | 0.090 |
Why?
|
INDEL Mutation | 1 | 2011 | 266 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 487 | 0.090 |
Why?
|
Diabetes, Gestational | 2 | 2017 | 1241 | 0.090 |
Why?
|
Contraceptives, Oral | 1 | 1992 | 554 | 0.090 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2012 | 546 | 0.090 |
Why?
|
Chromosome Mapping | 2 | 2017 | 4624 | 0.090 |
Why?
|
Fear | 1 | 2019 | 1462 | 0.090 |
Why?
|
Brassica | 3 | 2007 | 40 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 829 | 0.090 |
Why?
|
Phosphorus | 1 | 2011 | 335 | 0.090 |
Why?
|
Veterinary Medicine | 1 | 1989 | 21 | 0.090 |
Why?
|
Analgesics, Non-Narcotic | 2 | 2007 | 370 | 0.090 |
Why?
|
Stress, Psychological | 3 | 2015 | 4455 | 0.090 |
Why?
|
Estrogen Replacement Therapy | 3 | 2011 | 1206 | 0.090 |
Why?
|
Costs and Cost Analysis | 2 | 2013 | 1673 | 0.090 |
Why?
|
Glycosylation | 1 | 2013 | 1095 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2011 | 362 | 0.080 |
Why?
|
Diarrhea | 1 | 2016 | 1317 | 0.080 |
Why?
|
Philadelphia | 2 | 2023 | 265 | 0.080 |
Why?
|
Fontan Procedure | 1 | 2016 | 791 | 0.080 |
Why?
|
Models, Statistical | 7 | 2014 | 5070 | 0.080 |
Why?
|
Receptors, Leptin | 2 | 2001 | 350 | 0.080 |
Why?
|
Meat Products | 2 | 2017 | 96 | 0.080 |
Why?
|
Cognition | 4 | 2024 | 6953 | 0.080 |
Why?
|
Survival Analysis | 5 | 2019 | 10112 | 0.080 |
Why?
|
Parenting | 1 | 2015 | 695 | 0.080 |
Why?
|
Drug Users | 1 | 2011 | 134 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2022 | 26183 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1185 | 0.080 |
Why?
|
Personality | 1 | 2012 | 552 | 0.080 |
Why?
|
Activities of Daily Living | 2 | 2017 | 2414 | 0.080 |
Why?
|
Glaucoma, Open-Angle | 1 | 2016 | 734 | 0.080 |
Why?
|
Skin Neoplasms | 5 | 2011 | 5797 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1136 | 0.080 |
Why?
|
Europe | 4 | 2024 | 3420 | 0.080 |
Why?
|
Homozygote | 4 | 2009 | 1788 | 0.080 |
Why?
|
Aspirin | 4 | 2010 | 3131 | 0.080 |
Why?
|
Time | 1 | 2010 | 543 | 0.080 |
Why?
|
Quantitative Trait Loci | 4 | 2016 | 2100 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2020 | 5199 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2011 | 221 | 0.080 |
Why?
|
Apolipoprotein A-I | 2 | 2020 | 294 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2008 | 320 | 0.080 |
Why?
|
Retinal Diseases | 1 | 2015 | 702 | 0.080 |
Why?
|
Eggs | 2 | 2020 | 183 | 0.080 |
Why?
|
Homeostasis | 1 | 1999 | 3301 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 682 | 0.080 |
Why?
|
Prostatism | 1 | 2008 | 14 | 0.080 |
Why?
|
Vehicle Emissions | 1 | 2013 | 655 | 0.080 |
Why?
|
Lipoprotein Lipase | 1 | 2009 | 133 | 0.080 |
Why?
|
Receptors, Epoprostenol | 1 | 2008 | 12 | 0.080 |
Why?
|
Hysterectomy | 3 | 2023 | 904 | 0.080 |
Why?
|
Carotid Artery Diseases | 1 | 2015 | 872 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1611 | 0.080 |
Why?
|
Soybean Proteins | 1 | 2008 | 55 | 0.080 |
Why?
|
Medical History Taking | 2 | 2010 | 772 | 0.080 |
Why?
|
Policy | 2 | 2022 | 511 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2018 | 7985 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1780 | 0.080 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2010 | 783 | 0.070 |
Why?
|
Antigens, CD | 3 | 2004 | 3997 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2800 | 0.070 |
Why?
|
Dioxins | 1 | 2008 | 92 | 0.070 |
Why?
|
Toes | 3 | 2004 | 209 | 0.070 |
Why?
|
Testosterone | 3 | 2012 | 2471 | 0.070 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 2 | 1998 | 61 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
Drug Interactions | 4 | 2005 | 1414 | 0.070 |
Why?
|
NF-kappa B | 2 | 2013 | 2472 | 0.070 |
Why?
|
Ovariectomy | 2 | 2023 | 610 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2016 | 3364 | 0.070 |
Why?
|
E-Selectin | 1 | 2010 | 576 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2002 | 3432 | 0.070 |
Why?
|
Interviews as Topic | 1 | 2015 | 2676 | 0.070 |
Why?
|
Hypertriglyceridemia | 2 | 2011 | 293 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2001 | 2276 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2016 | 6013 | 0.070 |
Why?
|
Thrombosis | 1 | 2001 | 2929 | 0.070 |
Why?
|
Kaempferols | 2 | 2007 | 21 | 0.070 |
Why?
|
Gene Expression | 2 | 2018 | 7583 | 0.070 |
Why?
|
Duodenal Ulcer | 2 | 1997 | 121 | 0.070 |
Why?
|
Hearing Loss | 1 | 2014 | 780 | 0.070 |
Why?
|
Mercury Poisoning | 1 | 2006 | 32 | 0.070 |
Why?
|
Leukocytes | 2 | 2017 | 2025 | 0.070 |
Why?
|
Attitude | 1 | 2012 | 777 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2015 | 14641 | 0.070 |
Why?
|
Riboflavin | 3 | 2015 | 105 | 0.070 |
Why?
|
Glioma | 1 | 2021 | 3418 | 0.070 |
Why?
|
Hydroxycholecalciferols | 1 | 2006 | 44 | 0.070 |
Why?
|
Glutamine | 2 | 2023 | 575 | 0.070 |
Why?
|
Vitamin K | 1 | 2008 | 318 | 0.070 |
Why?
|
Methylation | 2 | 2007 | 1080 | 0.070 |
Why?
|
Heart Failure | 5 | 2014 | 11593 | 0.070 |
Why?
|
Fetal Development | 1 | 2011 | 766 | 0.070 |
Why?
|
Statistics as Topic | 4 | 2017 | 2359 | 0.060 |
Why?
|
Sodium Channels | 1 | 2007 | 343 | 0.060 |
Why?
|
Calcium | 3 | 2014 | 5721 | 0.060 |
Why?
|
Cardiology | 1 | 1997 | 1667 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2013 | 2221 | 0.060 |
Why?
|
Methionine | 4 | 1998 | 569 | 0.060 |
Why?
|
Epidemiology | 1 | 2008 | 279 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2015 | 1996 | 0.060 |
Why?
|
Diverticulum, Colon | 2 | 1995 | 32 | 0.060 |
Why?
|
Diverticulum | 2 | 1998 | 137 | 0.060 |
Why?
|
Life Change Events | 3 | 2021 | 953 | 0.060 |
Why?
|
Costa Rica | 3 | 2012 | 177 | 0.060 |
Why?
|
Affect | 1 | 2013 | 1480 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 677 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 812 | 0.060 |
Why?
|
Cross-Cultural Comparison | 2 | 2001 | 635 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 1999 | 567 | 0.060 |
Why?
|
Kidney | 3 | 2006 | 7016 | 0.060 |
Why?
|
Divorce | 1 | 2005 | 76 | 0.060 |
Why?
|
Physical Endurance | 3 | 2013 | 362 | 0.060 |
Why?
|
Iron | 4 | 2024 | 1786 | 0.060 |
Why?
|
Sampling Studies | 2 | 2004 | 614 | 0.060 |
Why?
|
Taiwan | 3 | 2000 | 504 | 0.060 |
Why?
|
Carcinogens | 1 | 2006 | 451 | 0.060 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 215 | 0.060 |
Why?
|
Fish Oils | 2 | 2005 | 481 | 0.060 |
Why?
|
Receptor, Melanocortin, Type 4 | 2 | 2015 | 128 | 0.060 |
Why?
|
Bread | 1 | 2023 | 23 | 0.060 |
Why?
|
Emotions | 2 | 2013 | 2734 | 0.060 |
Why?
|
Drinking | 3 | 2001 | 199 | 0.060 |
Why?
|
Causality | 5 | 2016 | 1241 | 0.060 |
Why?
|
Chromium | 1 | 2004 | 132 | 0.060 |
Why?
|
Citrus sinensis | 2 | 2014 | 14 | 0.060 |
Why?
|
Anticarcinogenic Agents | 2 | 2003 | 249 | 0.060 |
Why?
|
Vascular Diseases | 2 | 2003 | 1160 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 938 | 0.060 |
Why?
|
Wrist Injuries | 2 | 1998 | 214 | 0.060 |
Why?
|
Blood Preservation | 1 | 2004 | 168 | 0.060 |
Why?
|
Iron, Dietary | 1 | 2024 | 148 | 0.060 |
Why?
|
Ice | 1 | 2004 | 102 | 0.060 |
Why?
|
Thiamine | 1 | 2004 | 160 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2016 | 1694 | 0.060 |
Why?
|
Monosaccharides | 1 | 2023 | 68 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2024 | 64378 | 0.050 |
Why?
|
Accidents | 2 | 2002 | 166 | 0.050 |
Why?
|
Food Industry | 1 | 2003 | 67 | 0.050 |
Why?
|
Erythrocyte Membrane | 1 | 2004 | 439 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 748 | 0.050 |
Why?
|
Hematinics | 1 | 2006 | 280 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 4342 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 139 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6068 | 0.050 |
Why?
|
ROC Curve | 1 | 2011 | 3563 | 0.050 |
Why?
|
Dental Amalgam | 1 | 2003 | 65 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 604 | 0.050 |
Why?
|
Dental Caries Susceptibility | 1 | 2022 | 26 | 0.050 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 963 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2004 | 1539 | 0.050 |
Why?
|
Water Pollutants, Chemical | 1 | 2006 | 354 | 0.050 |
Why?
|
Coumarins | 1 | 2022 | 118 | 0.050 |
Why?
|
Heart Rate | 2 | 2013 | 4166 | 0.050 |
Why?
|
Expressed Emotion | 1 | 2003 | 92 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2003 | 137 | 0.050 |
Why?
|
Proline | 1 | 2024 | 456 | 0.050 |
Why?
|
Data Collection | 2 | 1998 | 3322 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2007 | 1150 | 0.050 |
Why?
|
Lutein | 5 | 2003 | 122 | 0.050 |
Why?
|
Food Service, Hospital | 1 | 2021 | 18 | 0.050 |
Why?
|
Israel | 1 | 2024 | 721 | 0.050 |
Why?
|
Urinalysis | 1 | 2024 | 368 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2023 | 278 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2008 | 2564 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 479 | 0.050 |
Why?
|
Calibration | 1 | 2024 | 814 | 0.050 |
Why?
|
Fusobacterium | 1 | 2021 | 54 | 0.050 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2001 | 28 | 0.050 |
Why?
|
Eicosanoids | 1 | 2003 | 278 | 0.050 |
Why?
|
Prostate-Specific Antigen | 2 | 2003 | 2528 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3603 | 0.050 |
Why?
|
Prebiotics | 1 | 2021 | 41 | 0.050 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 298 | 0.050 |
Why?
|
Methylmalonic Acid | 1 | 2001 | 49 | 0.050 |
Why?
|
Child Development | 1 | 2013 | 2285 | 0.050 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11152 | 0.050 |
Why?
|
Taxes | 1 | 2023 | 221 | 0.050 |
Why?
|
Nova Scotia | 1 | 2020 | 34 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2021 | 98 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 80 | 0.050 |
Why?
|
Double-Blind Method | 4 | 2021 | 12262 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2115 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4373 | 0.050 |
Why?
|
Zinc | 2 | 2004 | 687 | 0.050 |
Why?
|
Morbidity | 2 | 2020 | 1754 | 0.050 |
Why?
|
Netherlands | 3 | 2015 | 2212 | 0.050 |
Why?
|
Social Responsibility | 1 | 2003 | 386 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 2239 | 0.050 |
Why?
|
Preventive Medicine | 1 | 2002 | 247 | 0.040 |
Why?
|
Databases, Factual | 3 | 2013 | 7980 | 0.040 |
Why?
|
Endometrial Neoplasms | 1 | 2010 | 1357 | 0.040 |
Why?
|
Onions | 2 | 2014 | 6 | 0.040 |
Why?
|
Carnitine | 1 | 2021 | 252 | 0.040 |
Why?
|
Apolipoproteins | 2 | 2019 | 319 | 0.040 |
Why?
|
Anger | 1 | 2003 | 401 | 0.040 |
Why?
|
Hydrogen Sulfide | 1 | 2021 | 141 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3705 | 0.040 |
Why?
|
Recurrence | 4 | 2018 | 8426 | 0.040 |
Why?
|
Carbon | 1 | 2023 | 667 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2004 | 672 | 0.040 |
Why?
|
Spouses | 1 | 2002 | 279 | 0.040 |
Why?
|
Age of Onset | 2 | 2021 | 3298 | 0.040 |
Why?
|
Cheese | 1 | 2019 | 38 | 0.040 |
Why?
|
Quercetin | 2 | 2015 | 96 | 0.040 |
Why?
|
Southeastern United States | 1 | 2019 | 92 | 0.040 |
Why?
|
Breast Neoplasms | 7 | 2010 | 21017 | 0.040 |
Why?
|
Yogurt | 1 | 2019 | 71 | 0.040 |
Why?
|
Probability | 2 | 2003 | 2467 | 0.040 |
Why?
|
Retrospective Studies | 13 | 2015 | 80168 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 1 | 2003 | 747 | 0.040 |
Why?
|
Hyperlipidemias | 3 | 2005 | 772 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3783 | 0.040 |
Why?
|
Antidepressive Agents | 3 | 2016 | 2889 | 0.040 |
Why?
|
Nursing Research | 1 | 2020 | 80 | 0.040 |
Why?
|
Social Isolation | 1 | 2002 | 362 | 0.040 |
Why?
|
Observation | 1 | 2001 | 311 | 0.040 |
Why?
|
Hemostasis | 1 | 2001 | 466 | 0.040 |
Why?
|
Apolipoprotein B-100 | 2 | 2013 | 155 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2011 | 14354 | 0.040 |
Why?
|
Blood Donors | 1 | 2001 | 343 | 0.040 |
Why?
|
5,10-Methylenetetrahydrofolate Reductase (FADH2) | 1 | 1998 | 2 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 869 | 0.040 |
Why?
|
Remission Induction | 1 | 2024 | 2388 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2205 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 2 | 2004 | 3755 | 0.040 |
Why?
|
Xanthophylls | 4 | 2000 | 94 | 0.040 |
Why?
|
Antibodies | 1 | 2006 | 2420 | 0.040 |
Why?
|
Snoring | 1 | 2000 | 206 | 0.040 |
Why?
|
China | 1 | 2024 | 2333 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2000 | 3485 | 0.040 |
Why?
|
Lactase | 1 | 2018 | 71 | 0.040 |
Why?
|
Monitoring, Immunologic | 1 | 1998 | 98 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2011 | 3533 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2004 | 1156 | 0.040 |
Why?
|
Sphingomyelins | 1 | 2018 | 103 | 0.040 |
Why?
|
France | 1 | 1999 | 499 | 0.040 |
Why?
|
Starch | 1 | 2018 | 80 | 0.040 |
Why?
|
Ferritins | 1 | 2001 | 597 | 0.040 |
Why?
|
Cattle | 1 | 2023 | 3845 | 0.040 |
Why?
|
Electrocoagulation | 1 | 1998 | 152 | 0.040 |
Why?
|
Factor Analysis, Statistical | 4 | 2002 | 999 | 0.040 |
Why?
|
Oxygen Isotopes | 1 | 2017 | 43 | 0.040 |
Why?
|
Skinfold Thickness | 1 | 2017 | 158 | 0.040 |
Why?
|
Periodicity | 1 | 1999 | 348 | 0.040 |
Why?
|
Arsenic Poisoning | 1 | 1997 | 55 | 0.040 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 608 | 0.040 |
Why?
|
Deuterium | 1 | 2017 | 105 | 0.040 |
Why?
|
Employment | 1 | 2004 | 1112 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2006 | 1704 | 0.040 |
Why?
|
Fabaceae | 1 | 2017 | 103 | 0.040 |
Why?
|
Taq Polymerase | 2 | 2007 | 20 | 0.040 |
Why?
|
Climate | 1 | 2018 | 147 | 0.040 |
Why?
|
Proinsulin | 1 | 2017 | 135 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2001 | 1844 | 0.040 |
Why?
|
Heart Arrest | 1 | 2007 | 1494 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1501 | 0.040 |
Why?
|
Probiotics | 1 | 2021 | 377 | 0.040 |
Why?
|
Intention | 1 | 2020 | 345 | 0.030 |
Why?
|
Food, Preserved | 1 | 2016 | 13 | 0.030 |
Why?
|
Universities | 1 | 2022 | 993 | 0.030 |
Why?
|
Registries | 3 | 2020 | 8175 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 369 | 0.030 |
Why?
|
Frail Elderly | 1 | 2022 | 751 | 0.030 |
Why?
|
Nutrigenomics | 1 | 2016 | 24 | 0.030 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.030 |
Why?
|
Eicosanoic Acids | 1 | 2015 | 15 | 0.030 |
Why?
|
Immunoassay | 2 | 1998 | 746 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1713 | 0.030 |
Why?
|
Musa | 1 | 2016 | 8 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2017 | 384 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1651 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6293 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 4745 | 0.030 |
Why?
|
Substance-Related Disorders | 3 | 2016 | 4402 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 392 | 0.030 |
Why?
|
Diet, Reducing | 1 | 2019 | 485 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 699 | 0.030 |
Why?
|
Stearic Acids | 1 | 2015 | 56 | 0.030 |
Why?
|
Finasteride | 1 | 1996 | 90 | 0.030 |
Why?
|
Caffeic Acids | 1 | 2015 | 15 | 0.030 |
Why?
|
Oxidoreductases | 1 | 1998 | 412 | 0.030 |
Why?
|
Coumaric Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2015 | 8506 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1206 | 0.030 |
Why?
|
Candy | 2 | 2012 | 36 | 0.030 |
Why?
|
Hesperidin | 1 | 2015 | 18 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1628 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1705 | 0.030 |
Why?
|
Introns | 1 | 2018 | 978 | 0.030 |
Why?
|
Violence | 1 | 2021 | 934 | 0.030 |
Why?
|
Dentists | 3 | 2003 | 177 | 0.030 |
Why?
|
Cataract Extraction | 1 | 1999 | 465 | 0.030 |
Why?
|
Palmitic Acid | 1 | 2015 | 149 | 0.030 |
Why?
|
Postoperative Complications | 5 | 1998 | 15637 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2014 | 32 | 0.030 |
Why?
|
Single Person | 1 | 2014 | 31 | 0.030 |
Why?
|
Cholesterol, Dietary | 3 | 2003 | 223 | 0.030 |
Why?
|
Myocardium | 1 | 2007 | 4690 | 0.030 |
Why?
|
Troponin I | 1 | 1999 | 632 | 0.030 |
Why?
|
Sunlight | 2 | 2011 | 337 | 0.030 |
Why?
|
Glucose | 2 | 2023 | 4336 | 0.030 |
Why?
|
Smell | 1 | 2016 | 259 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2000 | 1077 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2111 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1788 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 159 | 0.030 |
Why?
|
Tuna | 2 | 2004 | 18 | 0.030 |
Why?
|
Fissure in Ano | 1 | 1993 | 14 | 0.030 |
Why?
|
Troponin T | 1 | 1999 | 761 | 0.030 |
Why?
|
Analgesics | 2 | 2006 | 1064 | 0.030 |
Why?
|
Fractures, Bone | 2 | 1998 | 2040 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 1999 | 1516 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2015 | 392 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2001 | 1373 | 0.030 |
Why?
|
Physicians | 1 | 2011 | 4580 | 0.030 |
Why?
|
Single-Blind Method | 3 | 2004 | 1570 | 0.030 |
Why?
|
Cataract | 1 | 1999 | 827 | 0.030 |
Why?
|
Attention | 1 | 2024 | 2387 | 0.030 |
Why?
|
Brachial Artery | 1 | 2015 | 365 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2004 | 5349 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 282 | 0.030 |
Why?
|
Fetal Blood | 1 | 2000 | 1343 | 0.030 |
Why?
|
Gestational Age | 2 | 2018 | 3565 | 0.030 |
Why?
|
Plant Leaves | 1 | 2013 | 150 | 0.030 |
Why?
|
Selenoproteins | 1 | 2014 | 214 | 0.030 |
Why?
|
Proanthocyanidins | 1 | 2012 | 20 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2006 | 4938 | 0.030 |
Why?
|
Quality Control | 2 | 2011 | 825 | 0.030 |
Why?
|
Steroid Hydroxylases | 1 | 2012 | 96 | 0.030 |
Why?
|
Vasectomy | 1 | 1993 | 51 | 0.030 |
Why?
|
Neutron Activation Analysis | 1 | 2012 | 35 | 0.030 |
Why?
|
Marriage | 1 | 2014 | 350 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2018 | 460 | 0.030 |
Why?
|
Pyrus | 1 | 2012 | 13 | 0.030 |
Why?
|
Spain | 1 | 2014 | 488 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2002 | 2307 | 0.030 |
Why?
|
Cost of Illness | 1 | 2002 | 1936 | 0.030 |
Why?
|
Poverty Areas | 1 | 2014 | 264 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2016 | 788 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5691 | 0.030 |
Why?
|
Republic of Korea | 1 | 2014 | 565 | 0.030 |
Why?
|
Fatty Acid Desaturases | 1 | 2012 | 101 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 316 | 0.020 |
Why?
|
Angina Pectoris | 1 | 2016 | 958 | 0.020 |
Why?
|
Australia | 1 | 2016 | 1276 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2629 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2004 | 2747 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3227 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1997 | 1630 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 1995 | 433 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1735 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2013 | 385 | 0.020 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2012 | 174 | 0.020 |
Why?
|
Signal Transduction | 2 | 2012 | 23342 | 0.020 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 728 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 13961 | 0.020 |
Why?
|
Fluorescence | 1 | 2013 | 749 | 0.020 |
Why?
|
Oral Health | 1 | 1996 | 486 | 0.020 |
Why?
|
Infant, Premature | 1 | 2020 | 2092 | 0.020 |
Why?
|
Albuminuria | 1 | 2015 | 650 | 0.020 |
Why?
|
Greece | 3 | 1997 | 336 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6493 | 0.020 |
Why?
|
Vasodilation | 1 | 2015 | 960 | 0.020 |
Why?
|
Colorimetry | 1 | 2011 | 148 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2014 | 597 | 0.020 |
Why?
|
Genome, Human | 1 | 2003 | 4416 | 0.020 |
Why?
|
Genetic Testing | 1 | 2003 | 3530 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2015 | 759 | 0.020 |
Why?
|
Hydrogenation | 1 | 2010 | 20 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1998 | 1096 | 0.020 |
Why?
|
Carcinoma | 2 | 1999 | 2330 | 0.020 |
Why?
|
Blood Proteins | 1 | 2016 | 1173 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2013 | 652 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1594 | 0.020 |
Why?
|
Colectomy | 1 | 1995 | 692 | 0.020 |
Why?
|
Isomerism | 1 | 2010 | 197 | 0.020 |
Why?
|
Postal Service | 1 | 1990 | 95 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8143 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 1994 | 505 | 0.020 |
Why?
|
Memory Disorders | 1 | 2017 | 1197 | 0.020 |
Why?
|
Mastectomy | 1 | 1998 | 1832 | 0.020 |
Why?
|
Appendectomy | 1 | 1993 | 431 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1134 | 0.020 |
Why?
|
Carbonated Beverages | 1 | 2011 | 209 | 0.020 |
Why?
|
Colonoscopy | 4 | 2004 | 1388 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1433 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2002 | 3727 | 0.020 |
Why?
|
Risk-Taking | 1 | 1995 | 1034 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2904 | 0.020 |
Why?
|
Interleukin-18 | 1 | 2011 | 250 | 0.020 |
Why?
|
Electrocardiography | 2 | 2001 | 6363 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1740 | 0.020 |
Why?
|
Cytokines | 1 | 2004 | 7338 | 0.020 |
Why?
|
Base Sequence | 2 | 2013 | 12436 | 0.020 |
Why?
|
Public Policy | 1 | 1993 | 559 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2003 | 3867 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2011 | 220 | 0.020 |
Why?
|
Vitis | 1 | 2008 | 19 | 0.020 |
Why?
|
Muscle Strength | 1 | 2013 | 618 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2005 | 13245 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2010 | 350 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 786 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3099 | 0.020 |
Why?
|
Biostatistics | 1 | 2010 | 164 | 0.020 |
Why?
|
Mexico | 1 | 2011 | 758 | 0.020 |
Why?
|
Herpes Labialis | 1 | 1988 | 28 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11070 | 0.020 |
Why?
|
Hernia, Inguinal | 1 | 1991 | 220 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1995 | 1165 | 0.020 |
Why?
|
Workload | 1 | 2014 | 847 | 0.020 |
Why?
|
Quebec | 1 | 2008 | 140 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2007 | 72 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1256 | 0.020 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2007 | 102 | 0.020 |
Why?
|
Social Environment | 1 | 2013 | 1023 | 0.020 |
Why?
|
Functional Laterality | 1 | 1994 | 2253 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2013 | 1011 | 0.020 |
Why?
|
Anxiety | 1 | 2002 | 4539 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1444 | 0.020 |
Why?
|
Self Care | 1 | 2013 | 794 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1995 | 1327 | 0.020 |
Why?
|
Surgical Procedures, Operative | 2 | 1997 | 1911 | 0.020 |
Why?
|
Pain, Postoperative | 2 | 1994 | 1721 | 0.020 |
Why?
|
Mass Screening | 2 | 2008 | 5427 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 908 | 0.020 |
Why?
|
Mice | 2 | 2011 | 81101 | 0.020 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2007 | 141 | 0.020 |
Why?
|
Lymphatic Metastasis | 3 | 2000 | 2943 | 0.020 |
Why?
|
Child Behavior | 1 | 2013 | 847 | 0.020 |
Why?
|
Health Policy | 1 | 2019 | 2677 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2012 | 3069 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2189 | 0.020 |
Why?
|
Phospholipases A2 | 1 | 2007 | 197 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1218 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1845 | 0.020 |
Why?
|
Brain | 1 | 2013 | 26947 | 0.020 |
Why?
|
Echocardiography | 1 | 1999 | 4962 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2012 | 820 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2006 | 2154 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36284 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3709 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 2976 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 1998 | 3609 | 0.020 |
Why?
|
Digestive System Neoplasms | 1 | 2006 | 81 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.020 |
Why?
|
Science | 1 | 2008 | 239 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3615 | 0.020 |
Why?
|
Isoenzymes | 2 | 2001 | 1686 | 0.020 |
Why?
|
Stroke Volume | 1 | 1999 | 5460 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 3992 | 0.020 |
Why?
|
Biopsy | 1 | 1997 | 6768 | 0.020 |
Why?
|
Chromium Compounds | 1 | 2004 | 7 | 0.020 |
Why?
|
Rectal Neoplasms | 1 | 1994 | 1152 | 0.020 |
Why?
|
Lower Extremity | 1 | 2013 | 1188 | 0.020 |
Why?
|
Rats | 1 | 2001 | 23679 | 0.020 |
Why?
|
Albumins | 1 | 2007 | 575 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 2008 | 1172 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2006 | 638 | 0.010 |
Why?
|
Ultraviolet Rays | 2 | 2006 | 1076 | 0.010 |
Why?
|
Self Concept | 1 | 1990 | 1041 | 0.010 |
Why?
|
Meperidine | 2 | 1994 | 38 | 0.010 |
Why?
|
Disease | 1 | 2010 | 671 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2013 | 2131 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1734 | 0.010 |
Why?
|
Hyperplasia | 2 | 2000 | 1154 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2015 | 2980 | 0.010 |
Why?
|
Stents | 1 | 2016 | 3162 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2015 | 3072 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2895 | 0.010 |
Why?
|
Skin Pigmentation | 1 | 2006 | 276 | 0.010 |
Why?
|
Laparoscopy | 1 | 2016 | 2147 | 0.010 |
Why?
|
Jaw, Edentulous, Partially | 1 | 2004 | 85 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2007 | 1593 | 0.010 |
Why?
|
alpha-Tocopherol | 1 | 2003 | 126 | 0.010 |
Why?
|
Jaw, Edentulous | 1 | 2004 | 99 | 0.010 |
Why?
|
Solar System | 1 | 2002 | 12 | 0.010 |
Why?
|
Calorimetry | 1 | 2003 | 129 | 0.010 |
Why?
|
Luteolin | 1 | 2002 | 13 | 0.010 |
Why?
|
Exons | 1 | 2009 | 2387 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3754 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8611 | 0.010 |
Why?
|
Body Burden | 1 | 2003 | 158 | 0.010 |
Why?
|
Dental Restoration, Permanent | 1 | 2003 | 128 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2014 | 4451 | 0.010 |
Why?
|
Acute Disease | 2 | 2005 | 7225 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6821 | 0.010 |
Why?
|
Chlorides | 1 | 2004 | 663 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3261 | 0.010 |
Why?
|
Cadmium | 1 | 2002 | 215 | 0.010 |
Why?
|
Minerals | 1 | 2003 | 283 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 1694 | 0.010 |
Why?
|
Reference Standards | 1 | 2005 | 1003 | 0.010 |
Why?
|
Biological Availability | 1 | 2002 | 390 | 0.010 |
Why?
|
New York City | 1 | 2003 | 725 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 2004 | 539 | 0.010 |
Why?
|
Hawaii | 1 | 2001 | 101 | 0.010 |
Why?
|
Chemoprevention | 1 | 2003 | 326 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 1245 | 0.010 |
Why?
|
Stereoisomerism | 1 | 2001 | 613 | 0.010 |
Why?
|
Spinacia oleracea | 1 | 1999 | 12 | 0.010 |
Why?
|
History, 20th Century | 1 | 2008 | 2772 | 0.010 |
Why?
|
Environment | 1 | 2006 | 1118 | 0.010 |
Why?
|
Interleukins | 1 | 2004 | 783 | 0.010 |
Why?
|
Morphine | 2 | 1994 | 653 | 0.010 |
Why?
|
Mutation | 2 | 2009 | 29915 | 0.010 |
Why?
|
Grief | 1 | 2002 | 254 | 0.010 |
Why?
|
Appetite | 1 | 2001 | 247 | 0.010 |
Why?
|
Rectum | 2 | 1995 | 895 | 0.010 |
Why?
|
Allied Health Personnel | 1 | 2000 | 155 | 0.010 |
Why?
|
Myoglobin | 1 | 1999 | 159 | 0.010 |
Why?
|
Muscle Tonus | 1 | 1998 | 82 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 1125 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2003 | 2381 | 0.010 |
Why?
|
Hepatocyte Growth Factor | 1 | 1999 | 267 | 0.010 |
Why?
|
Sweden | 1 | 2001 | 1376 | 0.010 |
Why?
|
Suburban Population | 1 | 1998 | 53 | 0.010 |
Why?
|
Calcium Oxalate | 1 | 1998 | 75 | 0.010 |
Why?
|
Teaching | 2 | 1997 | 1168 | 0.010 |
Why?
|
Swimming | 1 | 1999 | 206 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1998 | 174 | 0.010 |
Why?
|
Fluid Therapy | 2 | 1992 | 578 | 0.010 |
Why?
|
Buttocks | 1 | 1998 | 111 | 0.010 |
Why?
|
Bicycling | 1 | 1999 | 176 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 426 | 0.010 |
Why?
|
Virginia | 1 | 1997 | 117 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1999 | 686 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 2001 | 529 | 0.010 |
Why?
|
Axilla | 1 | 1999 | 626 | 0.010 |
Why?
|
Dental Health Surveys | 1 | 1996 | 39 | 0.010 |
Why?
|
DMF Index | 1 | 1996 | 87 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4711 | 0.010 |
Why?
|
District of Columbia | 1 | 1996 | 160 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 1999 | 723 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1998 | 518 | 0.010 |
Why?
|
Nuclear Family | 1 | 1996 | 313 | 0.010 |
Why?
|
Chin | 1 | 1995 | 38 | 0.010 |
Why?
|
Thyroid Cartilage | 1 | 1995 | 43 | 0.010 |
Why?
|
Necrosis | 1 | 2000 | 1604 | 0.010 |
Why?
|
Nitrogen | 1 | 1997 | 350 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 17275 | 0.010 |
Why?
|
Hysterectomy, Vaginal | 1 | 1994 | 35 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1998 | 924 | 0.010 |
Why?
|
Running | 1 | 1999 | 483 | 0.010 |
Why?
|
Mathematical Computing | 1 | 1994 | 142 | 0.010 |
Why?
|
Phosphates | 1 | 1998 | 771 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9311 | 0.010 |
Why?
|
Cephalometry | 1 | 1995 | 382 | 0.010 |
Why?
|
Urination Disorders | 1 | 1994 | 240 | 0.010 |
Why?
|
Anus Diseases | 1 | 1993 | 55 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 1994 | 151 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2000 | 1303 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17617 | 0.010 |
Why?
|
Salivary Gland Neoplasms | 1 | 1997 | 304 | 0.010 |
Why?
|
Mouth | 1 | 1995 | 380 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2003 | 1809 | 0.010 |
Why?
|
Rectal Diseases | 1 | 1993 | 144 | 0.010 |
Why?
|
Tongue | 1 | 1995 | 404 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2006 | 7590 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1993 | 553 | 0.010 |
Why?
|
New York | 1 | 1994 | 874 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2000 | 3617 | 0.010 |
Why?
|
Patient Selection | 1 | 2003 | 4244 | 0.010 |
Why?
|
Cluster Analysis | 1 | 1998 | 2697 | 0.010 |
Why?
|
Posture | 1 | 1995 | 953 | 0.010 |
Why?
|
Paternal Age | 1 | 1991 | 87 | 0.010 |
Why?
|
Isotonic Solutions | 1 | 1991 | 116 | 0.010 |
Why?
|
Mental Disorders | 1 | 2011 | 6803 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22003 | 0.010 |
Why?
|
Visual Acuity | 1 | 2000 | 2642 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6127 | 0.010 |
Why?
|
Medical Records | 1 | 1996 | 1406 | 0.010 |
Why?
|
Pruritus | 1 | 1993 | 377 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 1996 | 1386 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1994 | 2210 | 0.010 |
Why?
|
Abscess | 1 | 1993 | 605 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2210 | 0.010 |
Why?
|
Laryngoscopy | 1 | 1995 | 705 | 0.010 |
Why?
|
Hyperglycemia | 1 | 1998 | 1368 | 0.010 |
Why?
|
Surgical Flaps | 1 | 1998 | 1669 | 0.010 |
Why?
|
Liver | 1 | 2005 | 7502 | 0.010 |
Why?
|
Head | 1 | 1995 | 921 | 0.010 |
Why?
|
Breast | 1 | 1998 | 1963 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2690 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 1996 | 2129 | 0.000 |
Why?
|
Wisconsin | 1 | 1988 | 122 | 0.000 |
Why?
|
Maternal Age | 1 | 1991 | 807 | 0.000 |
Why?
|
Anesthesia, Spinal | 1 | 1991 | 280 | 0.000 |
Why?
|
Prostatectomy | 1 | 1996 | 1956 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 7378 | 0.000 |
Why?
|
Intraoperative Care | 1 | 1991 | 766 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1997 | 4901 | 0.000 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1993 | 1110 | 0.000 |
Why?
|
Dental Care | 1 | 1988 | 279 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1996 | 8530 | 0.000 |
Why?
|
Societies, Medical | 1 | 1996 | 3891 | 0.000 |
Why?
|
Thyroid Neoplasms | 1 | 1997 | 2332 | 0.000 |
Why?
|
Pediatrics | 1 | 1996 | 3587 | 0.000 |
Why?
|
Medicare | 1 | 1997 | 6741 | 0.000 |
Why?
|
Pain | 1 | 1993 | 5065 | 0.000 |
Why?
|
Analgesics, Opioid | 1 | 1992 | 3765 | 0.000 |
Why?
|